Literature DB >> 3776816

Intermittent claudication: not so benign.

J D Coffman.   

Abstract

Mesh：

Year:  1986        PMID： 3776816     DOI： 10.1016/0002-8703(86)90339-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological approaches to the treatment of intermittent claudication.

Authors:  E G Bevan; P C Waller; L E Ramsay
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

2.  Ultrasonographic screening for abdominal aortic aneurysm: analysis of surgical decisions for cost-effectiveness.

Authors:  H Bengtsson; D Bergqvist; S Jendteg; B Lindgren; U Persson
Journal:  World J Surg       Date:  1989 May-Jun       Impact factor: 3.352

Review 3.  Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.

Authors:  K J Palmer; K L Goa
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

Review 4.  Intermittent claudication in older patients. Practical treatment guidelines.

Authors:  H Boccalon
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

5.  Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.

Authors: 
Journal:  BMJ       Date:  1989-02-18

6.  Non-invasive cardiac assessment in high risk patients (The GROUND study): rationale, objectives and design of a multi-center randomized controlled clinical trial.

Authors:  Alexander M de Vos; Annemarieke Rutten; Hester J van de Zaag-Loonen; Michiel L Bots; Riksta Dikkers; Robert A Buiskool; Willem P Mali; Daniel D Lubbers; Arend Mosterd; Mathias Prokop; Benno J Rensing; Maarten J Cramer; H Wouter van Es; Frans L Moll; Eric D van de Pavoordt; Pieter A Doevendans; Birgitta K Velthuis; Albert J Mackaay; Felix Zijlstra; Matthijs Oudkerk
Journal:  Trials       Date:  2008-08-01       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.